Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications.
about
Molecular monitoring of minimal residual disease in patients with multiple myeloma.Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypySignificantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemiaMalleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathologyMinimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms.A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells.Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.Detection of monoclonal B cells in general population from two different regions of Mexico.Detection of monoclonal IGH rearrangements in circulating cells from healthy first-degree relatives of patients with multiple myeloma.Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.
P2860
Q35668677-7C91B260-F5C7-48A0-87CD-E871768B3CF3Q35747546-0FE611D3-A9B3-4125-BF15-D6B45704BB04Q36684897-30A49B5C-DC87-42C4-AECB-18D3C8454677Q36872779-A3FD2750-2DC7-4289-B52C-9F36F9A2452BQ36981193-D93D213B-9D4E-4E82-B17B-E59BF1F0066EQ37238171-1EBB089D-017B-4295-A46C-72382CBAEB3FQ38017138-8C5902FF-3D97-49BE-93B2-EEE3B2C5A63FQ38377249-02FD7FB0-5406-436D-8E4F-738C24D1F83FQ41382639-B486153C-3837-49DC-8350-C701E0A53F74Q47996009-8DB61F65-6F48-4CA6-A9F8-39A7187B974AQ48149582-56A229FC-5A79-4C15-A435-5265233E95CCQ51751162-71873FB8-ECE1-47ED-8C43-7CF42F885445Q54300494-92081698-9C9E-4981-BD1A-76F019BC855A
P2860
Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Incomplete DJH rearrangements ...... ics and clinical implications.
@en
Incomplete DJH rearrangements ...... ics and clinical implications.
@nl
type
label
Incomplete DJH rearrangements ...... ics and clinical implications.
@en
Incomplete DJH rearrangements ...... ics and clinical implications.
@nl
prefLabel
Incomplete DJH rearrangements ...... ics and clinical implications.
@en
Incomplete DJH rearrangements ...... ics and clinical implications.
@nl
P2093
P2860
P50
P356
P1433
P1476
Incomplete DJH rearrangements ...... tics and clinical implications
@en
P2093
Balanzategui A
González D
González M
P2860
P2888
P304
P356
10.1038/SJ.LEU.2402964
P577
2003-07-01T00:00:00Z